Diclofenac Sodium Decreases Menstrual Flow
No, diclofenac sodium does not increase menstrual flow—it actually reduces it. As a prostaglandin synthesis inhibitor, diclofenac decreases menstrual bleeding volume, not increases it 1, 2.
Mechanism and Evidence
Diclofenac sodium works by inhibiting prostaglandin synthesis, which directly reduces both menstrual blood loss and associated pain. The FDA labeling confirms that diclofenac is a prostaglandin synthetase inhibitor 3, and this mechanism is precisely why NSAIDs like diclofenac are used therapeutically to manage heavy menstrual bleeding.
Clinical Trial Data
The strongest evidence comes from controlled trials demonstrating significant reductions in menstrual bleeding:
In a double-blind crossover study of 35 women with primary dysmenorrhea, diclofenac sodium (approximately 75 mg daily) significantly reduced menstrual bleeding as measured by both subjective rating (P < 0.001) and objective pad count (P < 0.05) 1
A comparative trial in 19 women with IUDs showed diclofenac sodium (50 mg three times on day 1, then 25 mg three times daily for 4 days) decreased menstrual blood loss from 128.3 ml to 102.1 ml (P < 0.01) 2
A 2022 Cochrane review examining interventions for IUD-associated bleeding confirmed that NSAIDs, including diclofenac, are used to treat heavy menstrual bleeding, not cause it 4
Important Clinical Considerations
Platelet Effects vs. Prostaglandin Effects
While diclofenac does increase platelet aggregation time slightly 3, this effect is not clinically significant for menstrual bleeding. The FDA labeling explicitly states that diclofenac "does not affect bleeding time" 3. The prostaglandin-inhibiting effect that reduces uterine bleeding far outweighs any theoretical antiplatelet concerns.
This differs from aspirin, which has more pronounced antiplatelet effects. A 2024 systematic review found that aspirin may increase menstrual blood loss in some women 5, but this finding does not apply to diclofenac.
Pregnancy Considerations
The FDA labeling notes that diclofenac "may inhibit uterine contraction" and should be avoided in late pregnancy 3. This uterine effect is consistent with its mechanism of reducing menstrual flow in non-pregnant women.
Clinical Bottom Line
If a patient reports increased menstrual bleeding while taking diclofenac, look for alternative causes rather than attributing it to the medication. The drug's pharmacology and clinical evidence consistently demonstrate a reduction in menstrual blood loss. Consider other factors such as:
- Underlying gynecological pathology
- Concurrent medications (particularly anticoagulants)
- IUD presence
- Hormonal changes
Diclofenac remains an appropriate treatment option for women with heavy menstrual bleeding or dysmenorrhea, typically dosed at 50-75 mg daily during menstruation 1, 2.